Peptone
Peptone is a biotechnology company using AI and experimental physics to design small-molecule therapeutics against intrinsically disordered proteins (IDPs) — the 6,200 human proteins that AlphaFold 3 cannot model. Founded in 2018 and based in Bellinzona, Switzerland, Peptone's proprietary HDX-MS platform and GPU-accelerated AI engines unlock previously "undruggable" targets implicated in cancer, neurodegeneration, and beyond.
Date, time and room information
Tuesday, May 5, 13:15 - 13:30, room Singapore
Category
Emerging biotech company
Title of the presentation
Design of small-molecule therapeutics against intrinsically disordered proteins (IDPs)
Speaker information
| Name | Position | Institution |
|---|---|---|
| Kamil Tamiola | CEO |
Further information for the sponsor website
